Prognostic role of SPARC expression in gastric cancer: A meta-analysis

Archives of Medical Science

Volumn 10, Issue 5, 2014, Pages 863-869

  Wang, Zishu ^a   Hao, Bo ^a   Yang, Yan ^a   Wang, Rui ^a   Li, Yumei ^a   Wu, Qiong ^a  

^a BENGBU MEDICAL COLLEGE   (China)

Author keywords

Gastric cancer; Prognosis; Secreted protein acidic and rich in cysteine; Tumor progression

Indexed keywords

OSTEONECTIN;

ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; GENE OVEREXPRESSION; HUMAN; LYMPH NODE METASTASIS; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR DIFFERENTIATION;

EID: 84908407510     PISSN: 17341922     EISSN: 18969151     Source Type: Journal    
DOI: 10.5114/aoms.2014.46207     Document Type: Article

References (20)

1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006; 24: 2137-50.
2. Ajani JA. Evolving chemotherapy for advanced gastric cancer. Oncologist 2005; 10 Suppl. 3: 49-58.
3. Brekken RA, Sage EH. SPARC, a matricellular protein: at the crossroads of cell-matrix communication: [Matrix Biology (2000) 569-580]. Matrix Biology 2001; 19: 815-27.
4. Funk SE, Sage EH. The Ca2 (+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells. Proc Nat Acad Sci 1991; 88: 2648-52.
5. Lane T, Sage E. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J 1994; 8: 163-73.
6. Framson PE, Sage EH. SPARC and tumor growth: where the seed meets the soil? J Cell Biochem 2004; 92: 679-90.
7. Arnold S, Mira E, Muneer S, et al. Forced expression of MMP9 rescues the loss of angiogenesis and abrogates metastasis of pancreatic tumors triggered by the absence of host SPARC. Exp Biol Med 2008; 233: 860-73.
8. Brown TJ, Shaw PA, Karp X, Huynh MH, Begley H, Ringuette MJ. Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer. Gynecol Oncol 1999; 75: 25-33.
9. Sato N, Fukushima N, Maehara N, et al. SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions. Oncogene 2003; 22: 5021-30.
10. Zhou L, Jiang Y, Yan T, et al. The prognostic role of cancer stem cells in breast cancer: a meta-analysis of published literatures. Breast Cancer Res Treat 2010; 122: 795-801.
11. Wang CS, Lin KH, Chen SL, Chan YF, Hsueh S. Overexpression of SPARC gene in human gastric carcinoma and its clinic - pathologic significance. Br J Cancer 2004; 91: 1924-30.
12. Franke K, Carl-McGrath S, Röhl FW, et al. Differential expression of SPARC in intestinal-type gastric cancer correlates with tumor progression and nodal spread. Translat Oncol 2009; 2: 310.
13. Zhao ZS, Wang YY, Chu YQ, Ye ZY, Tao HQ. SPARC is associated with gastric cancer progression and poor survival of patients. Clin Cancer Res 2010; 16: 260-8.
14. Jeung HC, Rha SY, Im CK, et al. A randomized phase 2 study of docetaxel and S-1 versus docetaxel and cisplatin in advanced gastric cancer with an evaluation of SPARC expression for personalized therapy. Cancer 2011; 117: 2050-7.
15. Han W, Yang ML, Zhai LL, et al. Relationship between expression of SPARC and TGF-beta1 with cancer cells proliferation in gastric cancer. J Clin Exp Pathol 2011; 27: 594-7.
16. Dong MX. Expression of SPARC in gastric carcinoma and its clinical significance. Qilu Med J 2011; 4: 105-7.
17. Li Y, Wu JF, Zhang H, et al. Expression of SPARC in gastric cancer. Acta Universitatis Medicinalis Anhui 2006; 41: 626-9.
18. Yang ML, Zhai LL, Ma LH, et al. Relationship between expression of SPARC and VEGF with tumor angiogenesis in gastric carcinoma. J Diag Pathol 2012; 19: 52-5.
19. Wang L, Yang M, Shan L, et al. The role of SPARC protein expression in the progress of gastric cancer. Pathol Oncol Res 2012; 18: 697-702.
20. Sato T, Oshima T, Yamamoto N, et al. Clinical significance of SPARC gene expression in patients with gastric cancer. J Surg Oncol 2013; 108: 364-8.